论文部分内容阅读
目的探讨丹红注射液对冠心病不稳定型心绞痛患者血清可溶性细胞间粘附因子-1(slCAM-1)、超敏C反应蛋白(hs-CRP)的影响。方法将96例不稳定型心绞痛患者随机分为丹红组(n=49)和对照组(n=47),对照组给予常规西药治疗,丹红组在对照组治疗基础上静脉滴注丹红注射液,对比分析两组疗效、血脂水平、炎症反应改善情况。结果治疗后,丹红组总有效率(91.84%)高于对照组(78.72%)(P<0.05);两组治疗后总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)降低,高密度脂蛋白胆固醇(HDL-C)水平升高,差异均有统计学意义(均P<0.05);丹红组TC、TG、LDL-C改善程度优于对照组(均P<0.05);两组治疗后hs-CRP、slCAM-1水平降低,丹红组降低程度优于对照组,差异均有统计学意义(均P<0.05)。结论丹红注射液有助于改善冠心病不稳定型心绞痛患者脂质代谢、炎性反应和临床症状。
Objective To investigate the effects of Danhong Injection on serum soluble intercellular adhesion molecule-1 (slCAM-1) and hs-CRP in patients with coronary heart disease and unstable angina pectoris. Methods Ninety-six patients with unstable angina were randomly divided into Danhong group (n = 49) and control group (n = 47). The control group was given conventional western medicine. Danhong group was treated with intravenous infusion of Danhong Injection, comparative analysis of two groups efficacy, blood lipid levels, inflammatory response to improve the situation. Results After treatment, the total effective rate (91.84%) in Danhong group was significantly higher than that in control group (78.72%) (P <0.05). After treatment, the total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) levels in the Danhong group were significantly higher than those in the control group (all P <0.05) (All P <0.05). The levels of hs-CRP and slCAM-1 in both groups decreased after treatment, but the reduction in Danhong group was better than that in control group (all P <0.05). Conclusion Danhong injection can improve lipid metabolism, inflammatory reaction and clinical symptoms in patients with coronary heart disease and unstable angina.